J Paul Marcoux MD

Hematologic Oncology, Thoracic Cancer

Staff Physician, Lowe Center for Thoracic Oncology. Dana Farber Cancer Institute Staff Physician, Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute

Join to view full profile

450 Brookline Ave# DanaBoston, MA 02215
Phone+1 617-632-3468
Fax+1 617-632-5786

Dr. Marcoux is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Marcoux's full profile Already have an account?

Education & Training

Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1994
UMass Chan Medical SchoolResidency, Internal Medicine, 1987 - 1991
University of Minnesota Medical SchoolClass of 1987

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 1990 - 2027
NH State Medical License 2024 - 2024
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2013-2015, 2017
CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2013-2015, 2017
CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2015, 2017

Publications & Presentations

PubMed

JAK inhibition may prevent drug hypersensitivity reactions.
Xiangmei Hua, Pranali N Shah, Gustavo A Velasquez, Lillian Sidky, George A Romar
JCI Insight. 2026-04-08
6 citations
Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes.
Catherine B Meador, Subba R Digumarthy, Beow Y Yeap, Yin P Hung, Mari Mino-Kenudson
Clinical Cancer Research. 2025-01-06
2 citations
Surgical complications and clinical outcomes after dose-escalated trimodality therapy for non-small cell lung cancer in the era of intensity-modulated radiotherapy.
Kevin X. Liu, Kailan Sierra-Davidson, Kevin Tyan, Lawrence T. Orlina, J. Paul Marcoux
Radiotherapy and Oncology. 2021-10-22